Patent · US Expired

Perfluoro-t-butyl-containing compounds for use in fluorine-19 NMR and/or MRI

US5324504A · kind A · utility

13Cited by
11References
2Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 4, 1993
Grant dateJun 28, 1994
Priority date
Expiry dateMar 4, 2013

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Accordingly, the present invention is directed to biological compounds derivatized so as to contain at least one perfluoro-t-butyl moiety for use in fluorine-19 NMR and/or MRI studies. The perfluoro-t-butyl (PFTB) moiety, ##STR1## is an excellent reported group for fluorine-19 NMR/MRI. It is a source of nine magnetically equivalent fluorine nuclei which generate a single intense resonance for each detection in spectroscopy or imaging. This signal is a sharp singlet, not split by neighboring nuclei or spread over a wide frequency range and eliminates any change of ghost images which might arise from multiple resonances. These spectral properties ensure a maximum signal-to-noise ratio (S/N) for readily detecting this moiety. The foregoing allows either reduction in the concentration of the derivatized compound, ability to use MRI instruments with lower field strengths, a reduction in imaging times, or a combination of the foregoing as a result of this moiety producing a single, sharp, intense resonance. Additionally, the PFTB moiety-containing compounds may be utilized to determine oxygen concentration in aqueous solutions present in animate and inanimate objects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.